Under the agreement, Apotex’s branded division, Searchlight Pharma, will seek regulatory approval and handle marketing and distribution in Canada
Immunology remained AbbVie’s largest and fastest-growing segment, delivering $30.41 billion in global net revenues,
N17350 is the company’s first-in-class tumor-directed therapeutic, designed to harness the ELANE pathway
_Limited_256_384.jpg)
A PRV is a tradable voucher granted by the FDA to encourage the development of new treatments for rare pediatric diseases
The approved Lacosamide Oral Solution is bioequivalent and therapeutically equivalent to the reference drug and will be manufactured at Indoco’s facility in Verna Industrial Area, Goa
Over a two-decade career, Dr. Berman has worked on more than a dozen clinical-stage immunotherapies, including senior leadership roles in developing four oncology biologics
The Union Budget 2026–27 accords strong priority to the upgradation and expansion of healthcare infrastructure and medical education
CSPC will receive an upfront $1.2 billion from AstraZeneca for access to eight programmes, AI molecular design capabilities, and the LiquidGel platform
The Tanuku facility will focus on the production of key therapeutic APIs, including Anti-Tussive, Anti-Coagulant (Blood Thinner), Anaesthetic, and Antidepressant molecules
Subscribe To Our Newsletter & Stay Updated
